Stifel Financial Portfolio holdings
AUM $103B
1-Year Return
17.55%
This Quarter Return
-16.44%
1 Year Return
+17.55%
3 Year Return
+67.43%
5 Year Return
+118.9%
10 Year Return
+263.91%
AUM
$36.2B
AUM Growth
-$11.8B
(-25%)
Cap. Flow
-$2.23B
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.62%
Holding
3,245
New
194
Increased
1,152
Reduced
1,301
Closed
422
Top Buys
| 1 |
Nike
NKE
|
+$146M |
| 2 |
Clorox
CLX
|
+$145M |
| 3 |
Ecolab
ECL
|
+$111M |
| 4 |
Visa
V
|
+$106M |
| 5 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$93.8M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$154M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$143M |
| 3 |
Qualcomm
QCOM
|
+$139M |
| 4 |
General Mills
GIS
|
+$137M |
| 5 |
Apple
AAPL
|
+$110M |
Sector Composition
| 1 | Technology | 14.42% |
| 2 | Healthcare | 11.91% |
| 3 | Financials | 8.67% |
| 4 | Consumer Staples | 8.33% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
iShares MSCI Pacific ex Japan ETF
EPP
$1.86B
| $1.01M | ﹤0.01% |
29,873
-2,919
| -9% | -$98.8K |
|
|
CTLT
1427
DELISTED
CATALENT, INC.
CTLT
| $1.01M | ﹤0.01% |
19,413
+2,096
| +12% | +$109K |
|
1428
Esperion Therapeutics
ESPR
$571M
| $1.01M | ﹤0.01% |
32,095
-3,503
| -10% | -$110K |
|
|
EXD
1429
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
| $1.01M | ﹤0.01% |
131,352
-9,836
| -7% | -$75.3K |
|
1430
SPS Commerce
SPSC
$4.06B
| $1M | ﹤0.01% |
20,912
-241,995
| -92% | -$11.6M |
|
1431
SmartFinancial
SMBK
$626M
| $1M | ﹤0.01% |
66,000
| – | – |
|
1432
Emergent Biosolutions
EBS
$425M
| $1M | ﹤0.01% |
17,321
+4,378
| +34% | +$254K |
|
1433
WesBanco
WSBC
$3.02B
| $1M | ﹤0.01% |
42,202
-2,440
| -5% | -$57.9K |
|
1434
iShares US Pharmaceuticals ETF
IHE
$571M
| $1M | ﹤0.01% |
22,320
-141
| -0.6% | -$6.32K |
|
1435
iShares Core 1-5 Year USD Bond ETF
ISTB
$4.46B
| $1M | ﹤0.01% |
19,849
-3,192
| -14% | -$161K |
|
1436
Fidelity MSCI Materials Index ETF
FMAT
$441M
| $1M | ﹤0.01% |
40,838
+7,854
| +24% | +$192K |
|
1437
Omnicell
OMCL
$1.48B
| $1M | ﹤0.01% |
14,868
-166,427
| -92% | -$11.2M |
|
|
CCXX.U
1438
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
| $1M | ﹤0.01% |
+100,000
| New | +$1M |
|
1439
Nicolet Bankshares
NIC
$1.98B
| $998K | ﹤0.01% |
18,287
| – | – |
|
1440
Spotify
SPOT
$145B
| $998K | ﹤0.01% |
8,246
+1,366
| +20% | +$165K |
|
1441
HealthEquity
HQY
$8.06B
| $997K | ﹤0.01% |
19,977
-131,473
| -87% | -$6.56M |
|
|
BTO
1442
John Hancock Financial Opportunities Fund
BTO
$714M
| $996K | ﹤0.01% |
54,019
+16,750
| +45% | +$309K |
|
1443
Univest Financial
UVSP
$880M
| $994K | ﹤0.01% |
60,961
-120
| -0.2% | -$1.96K |
|
1444
Brookfield Renewable
BEP
$7.3B
| $993K | ﹤0.01% |
44,180
-15
| -0% | -$337 |
|
1445
PTC
PTC
$24.7B
| $991K | ﹤0.01% |
17,082
-59,095
| -78% | -$3.43M |
|
1446
Viavi Solutions
VIAV
$2.71B
| $991K | ﹤0.01% |
89,504
-28,652
| -24% | -$317K |
|
1447
VanEck Biotech ETF
BBH
$347M
| $988K | ﹤0.01% |
7,725
+25
| +0.3% | +$3.2K |
|
1448
ICF International
ICFI
$1.85B
| $987K | ﹤0.01% |
14,231
-130,578
| -90% | -$9.06M |
|
1449
O-I Glass
OI
$1.97B
| $987K | ﹤0.01% |
138,100
-10,870
| -7% | -$77.7K |
|
1450
Equinor
EQNR
$61.1B
| $986K | ﹤0.01% |
81,561
+2,948
| +4% | +$35.6K |
|